[1]
Arenas, A., Ruedi, D., Walsen, G. and Ibañez, P. 2026. Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting. Journal of Gastrointestinal and Liver Diseases. 35, 3 (Sep. 2026), 499–500. DOI:https://doi.org/10.15403/jgld-6950.